NDC11 55910050508
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 55910-0505-08 | 55910-0505 |
| 55910-0505-8 | 55910-0505 |
| 55910-505-08 | 55910-505 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Mucus Relief DM Maximum Strength | DEXTROMETHORPHAN HBR, GUAIFENESIN | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 778dc0fb-30c3-4fbf-856a-7bca28181b39 | 2026-03-23 | Warnings | 55910-505-08 55910-505 55910050508 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.